Company
Viz.ai
Viz.ai closes the gaps between patients, clinicians, and life-saving treatments with its leading-edge, AI-powered care coordination platform — driven by over 50 advanced, FDA-cleared algorithms.
Also known as Viz.ai, Inc.
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- San Francisco, California, United States
- Founded
- 2016
- Customers
- providers and pharmaceutical and medical device companies
- Legal name
- Viz.ai, Inc.
- viz.ai (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Viz.ai uses artificial intelligence to accelerate care coordination, reducing systemic delays that stand between patients and life-saving treatments.
Funding snapshot
- Total raised
- $7.3MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $4.8M2017-05-09
Funding rounds
- Round, 2017
- $4.8M2017-05-09, SEC form D sold, 5 investors
- Round, 2016
- $2.5M2016-09-15, SEC form D sold, 10 investors
Products
- Web
- Viz Cardio
- Web
- Viz Neuro
- Web
- Viz Pulmonary Suite
- Web
- Viz Radiology
- Web
- Viz Trauma
- Web
- Viz Vascular
- Android
- Viz.ai (opens in a new tab)
Loading relationship preview